Frederic Massicotte, Ph.D.
Affiliations: | 2003 | Université de Montréal, Montréal, Canada |
Area:
Cell BiologyGoogle:
"Frederic Massicotte"Parents
Sign in to add mentor| Daniel Lajeunesse | grad student | 2003 | Université de Montréal | |
| (Implication et caracterisation du metabolisme anormal des osteoblastes arthrosiques humains de l'os sous-chondral dans le developpement de l'arthrose.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Choquette D, Bessette L, Sauvageau LC, et al. (2019) Fri0084 The Impact Of Il-6 And Tnf Inhibitors On Hemoglobin Levels: An Analysis From Rhumadata® Clinical Database And Registry Annals of the Rheumatic Diseases. 78: 705-705 |
| Choquette D, Bessette L, Sauvageau LC, et al. (2019) Ab0740 Use Of Secukinumab In Patients With Psoriatic Arthritis. Impacts Of Combination With Methotrexate Annals of the Rheumatic Diseases. 78: 1835-1835 |
| Choquette D, Bessette L, Sauvageau LC, et al. (2019) Sat0120 Comparative Effectiveness Of Tofacitinib And Tnf Inhibitors Since 2014. Impact Of Combination With Methotrexate Annals of the Rheumatic Diseases. 78: 1128-1128 |
| Choquette D, Bessette L, Alemao E, et al. (2017) SAT0195 Rituximab shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry Annals of the Rheumatic Diseases. 76: 1188-1188 |
| Choquette D, Bessette L, Alemao E, et al. (2017) FRI0230 Retention rates of tnf inhibitors and abatacept used as a first biologic dmard in the treatment of rheumatoid arthritis: 8 years of experience from the rhumadata® registry Annals of the Rheumatic Diseases. 76: 571-572 |
| Raynauld J-, Bessette L, Brown J, et al. (2016) THU0034 Use of Rituximab Compared To Anti-Tnf Agents as Second and Third-Line Therapy in Patients with Rheumatoid Arthritis. A 6-Year Follow-Up Report from The Rhumadata® Clinical Database and Registry Annals of the Rheumatic Diseases. 75: 190-190 |
| Bessette L, Brown J, Coupal L, et al. (2016) THU0035 Six Years Tocilizumab Use in Patients with Rheumatoid Arthritis with One Previous anti-TNF Agent Exposure: Comparison with Adalimumab and Etanercept from The Provincial Electronic Database and Registry Rhumadata® Annals of the Rheumatic Diseases. 75: 190-190 |
| Massicotte F, Aubry I, Martel-Pelletier J, et al. (2006) Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts. Arthritis Research & Therapy. 8: R177 |
| Massicotte F, Fernandes JC, Martel-Pelletier J, et al. (2006) Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. Bone. 38: 333-41 |
| Lajeunesse D, Massicotte F, Pelletier JP, et al. (2003) Subchondral bone sclerosis in osteoarthritis: not just an innocent bystander. Modern Rheumatology / the Japan Rheumatism Association. 13: 7-14 |